![William Lowry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
William Lowry is the founder of Pelage Pharmaceuticals, Inc. He held the title of President at the company, but is no longer active in that role.
Posizioni attive di William Lowry
Società | Posizione | Inizio |
---|---|---|
Pelage Pharmaceuticals, Inc.
![]() Pelage Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pelage Pharmaceuticals, Inc. is an American Los Angeles-based company that aims to deliver a scientifically-based, clinically-tested treatment for hair loss. The company's drug targets hair follicle stem cells responsible for hair growth, which is a novel mechanism for activating stem cells. The drug has the potential to promote robust hair growth in various forms of alopecia, including male and female pattern balding. Pelage Pharmaceuticals' topical small molecule drug platform stimulates hair growth without the need for invasive procedures or unwanted oral-systemic exposure. The company was founded by Heather Christofk, Michael Jung, William Lowry, and Daniel Gil, who has been the CEO since incorporation. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Pelage Pharmaceuticals, Inc.
![]() Pelage Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pelage Pharmaceuticals, Inc. is an American Los Angeles-based company that aims to deliver a scientifically-based, clinically-tested treatment for hair loss. The company's drug targets hair follicle stem cells responsible for hair growth, which is a novel mechanism for activating stem cells. The drug has the potential to promote robust hair growth in various forms of alopecia, including male and female pattern balding. Pelage Pharmaceuticals' topical small molecule drug platform stimulates hair growth without the need for invasive procedures or unwanted oral-systemic exposure. The company was founded by Heather Christofk, Michael Jung, William Lowry, and Daniel Gil, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- William Lowry